Specific sequelae symptoms of COVID-19 of Omicron variant in comparison with non-COVID-19 patients: a retrospective cohort study in Japan

被引:0
作者
Omori, Takahiro [1 ]
Hanafusa, Mariko [1 ,2 ]
Kondo, Nobuyuki [1 ,3 ]
Miyazaki, Yasunari [1 ,3 ]
Okada, Shusho [1 ,4 ]
Fujiwara, Takeo [1 ,5 ]
Kuramochi, Jin [1 ,3 ]
机构
[1] Kuramochi Clin Interpk, Dept Resp Med, Nakajima Cho 765-1, Utsunomiya, Tochigi 3210114, Japan
[2] Tokyo Med & Dent Univ, Dept Tokyo Metropolitan Hlth Policy Advisement, Tokyo, Japan
[3] Tokyo Med & Dent Univ, Dept Resp Med, Bunkyo Ku, Tokyo 1138510, Japan
[4] Tokyo Med & Dent Univ, Dept Hlth Policy, Tokyo, Japan
[5] Tokyo Med & Dent Univ, Dept Publ Hlth, Tokyo, Japan
关键词
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); Omicron; long-term sequela of coronavirus disease 2019 (long COVID); sequelae;
D O I
10.21037/jtd-23-1822
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: The specific long-term sequela of coronavirus disease 2019 (COVID-19), also known as long COVID of the Omicron variant remain unclear, due to a lack of cohort studies that include non-COVID patients with cold -like symptoms. The study was conducted to examine specific sequelae symptoms after severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, which is considered the Omicron variant, compared with patients who were never -infected. Methods: In this retrospective cohort study, we sent questionnaires in November 2022, targeting those who visited our fever outpatient unit of a single institution from July to September 2022. SARS-CoV-2 infection status was determined by SARS-CoV-2 polymerase chain reaction (PCR) test results during the study period collected in electronic medical records. Clinical characteristics at 30 days or more since the date of SARS-CoV-2 PCR test were assessed by the questionnaires. Multiple logistic regression was performed to investigate the independent association between SARS-CoV-2 infection and possible sequelae symptoms. Results: In total, valid responses were received from 4,779 patients (mean age: 41.4 years, standard deviation: 19.8 years old). Among them, 3,326 (69.6%) and 1,453 (30.4%) were SARS-CoV-2 PCR test positive and never -infected, respectively. We found that patients with SARS-CoV-2 infection were more likely to have a loss of taste or smell [odds ratio (OR) 4.55, 95% confidence interval (CI): 1.93, 10.71], hair loss (OR 3.19, 95% CI: 1.67, 6.09), neurocognitive symptoms (OR 1.95, 95% CI: 1.43, 2.65), and respiratory symptoms (OR 1.23, 95% CI: 1.03, 1.47) than never -infected patients. SARS-CoV-2 infection was not associated with common cold symptoms, chronic physical distress, or diarrhea as sequelae symptoms. Further, SARS-CoV-2 vaccination showed protective effects on sequelae of loss of taste or smell and hair loss. Conclusions: Loss of taste or smell, hair loss, neurocognitive symptoms, and respiratory symptoms were found to be specific sequelae of the SARS-CoV-2 Omicron variant. It is important not to miss these symptoms that follow SARS-CoV-2 infection and to recognize and manage the long COVID.
引用
收藏
页码:3170 / +
页数:13
相关论文
共 50 条
  • [31] COVID-19 long-term sequelae: Omicron versus Alpha and Delta variants
    Hernandez-Aceituno, Ana
    Garcia-Hernandez, Abigail
    Larumbe-Zabala, Eneko
    INFECTIOUS DISEASES NOW, 2023, 53 (05):
  • [32] Clinical characteristics and risk factors of non-mild outcomes in patients with Omicron variant COVID-19 in Shanghai, China
    Zhu, Wen
    Wang, Haowei
    Zhou, Hai
    Cheng, Lei
    Weng, Chao
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2024, 18 (01): : 44 - 52
  • [33] Effectiveness of remdesivir-based therapy for moderate COVID-19: comparison of Omicron and other variant phases
    Suzuki, Atsushi
    Fukumitsu, Kensuke
    Fukihara, Jun
    Katano, Takuma
    Kako, Hisashi
    Maeda, Yuri
    Ishii, Makoto
    Niimi, Akio
    Imaizumi, Kazuyoshi
    Yamaguchi, Etsuro
    JOURNAL OF CHEMOTHERAPY, 2024, 36 (02) : 127 - 132
  • [34] Covid-19 sequelae in working age patients: A systematic review
    d'Ettorre, Gabriele
    Gentilini Cacciola, Elio
    Santinelli, Letizia
    De Girolamo, Gabriella
    Spagnolello, Ornella
    Russo, Alessandro
    Tarsitani, Lorenzo
    Ciccozzi, Massimo
    Mastroianni, Claudio M.
    d'Ettorre, Gabriella
    Ceccarelli, Giancarlo
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (03) : 858 - 868
  • [35] Evaluation of Type I Interferon Treatment in Hospitalized COVID-19 Patients: A Retrospective Cohort Study
    Tat, Vivian Y.
    Huang, Pinghan
    Khanipov, Kamil
    Tat, Nathan Y.
    Tseng, Chien-Te Kent
    Golovko, George
    PATHOGENS, 2024, 13 (07):
  • [36] Efficacy of the COVID-19 vaccination in patients with asymptomatic or mild illness during the Omicron epidemic in Guangzhou: a multi-centre retrospective cohort study
    Xu, Yuanda
    Kong, Xuetao
    Huang, Weiqing
    Liang, Zijing
    Huang, Jinkun
    Li, Yimin
    Zhang, Nuofu
    Liu, Dan
    Guo, Wenwei
    Mei, Jiang
    ANNALS OF MEDICINE, 2024, 56 (01)
  • [37] Real-world efficacy and safety of azvudine in hospitalized older patients with COVID-19 during the omicron wave in China: A retrospective cohort study
    Zhu, Yuanchao
    Zhao, Fei
    Zhu, Yubing
    Li, Xingang
    Dong, Deshi
    Zhu, Bolin
    Li, Jianchun
    Hu, Xin
    Zhao, Zinan
    Xu, Wenfeng
    Jv, Yang
    Wang, Dandan
    Zheng, Yingming
    Dong, Yiwen
    Li, Lu
    Yang, Shilei
    Teng, Zhiyuan
    Lu, Ling
    Zhu, Jingwei
    Du, Linzhe
    Liu, Yunxin
    Jia, Lechuan
    Zhang, Qiujv
    Ma, Hui
    Zhao, Ana
    Jiang, Hongliu
    Xu, Xin
    Wang, Jinli
    Qian, Xuping
    Zhang, Wei
    Zheng, Tingting
    Yang, Chunxia
    Chen, Xuguang
    Liu, Kun
    Jiang, Huanhuan
    Qu, Dongxiang
    Song, Jia
    Cheng, Hua
    Sun, Wenfang
    Zhan, Hanqiu
    Li, Xiao
    Wang, Yafeng
    Wang, Aixia
    Liu, Li
    Yang, Lihua
    Zhang, Nan
    Chen, Shumin
    Ma, Jingjing
    Liu, Wei
    Du, Xiaoxiang
    ACTA PHARMACEUTICA SINICA B, 2025, 15 (01) : 123 - 132
  • [38] Clinical effects of traditional Chinese herbal medicine management in patients with COVID-19 sequelae: A hospital-based retrospective cohort study in Taiwan
    Hsieh, Po-Chun
    Yu, Chih-Chin
    Tzeng, I-Shiang
    Hsieh, Tsung-Han
    Wu, Chiu-Feng
    Ko, Li -Fan
    Lan, Chou -Chin
    Chao, You -Chen
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2024, 21 (07): : 1280 - 1291
  • [39] Patients Hospitalized for COVID-19 in the Periods of Delta and Omicron Variant Dominance in Greece: Determinants of Severity and Mortality
    Karageorgou, Vagia
    Papaioannou, Andriana I.
    Kallieri, Maria
    Blizou, Myrto
    Lampadakis, Stefanos
    Sfika, Maria
    Krouskos, Antonios
    Papavasileiou, Vasileios
    Strakosha, Franceska
    Vandorou, Kalliopi Theoni
    Siozos, Pavlos
    Christodoulou, Marina Moustaka
    Kontonasiou, Georgia
    Apollonatou, Vasiliki
    Antonogiannaki, Elvira Markella
    Kyriakopoulos, Christos
    Aggelopoulou, Christina
    Chronis, Christos
    Kostikas, Konstantinos
    Koukaki, Evangelia
    Sotiropoulou, Zoi
    Athanasopoulou, Athanasia
    Bakakos, Petros
    Schoini, Pinelopi
    Alevrakis, Emmanouil
    Poupos, Sotirios
    Chondrou, Evangelia
    Tsoukalas, Dionisios
    Chronaiou, Alexia
    Tsoukalas, George
    Koukidou, Sofia
    Hillas, Georgios
    Dimakou, Katerina
    Roukas, Konstantinos
    Nakou, Ifigeneia
    Chloros, Diamantis
    Fouka, Evangelia
    Papiris, Spyros A.
    Loukides, Stelios
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (18)
  • [40] Comparison of initial clinic characteristics of hospitalized patients in Suzhou City during the COVID-19 Omicron wave with ancestral variant wave
    Gu, Binbin
    Yao, Lin
    Zhu, Xin-yun
    Zou, Tao
    Feng, Yan-jun
    Yan, Jin-yu
    Zhang, Jian-ping
    Tang, Pei-jun
    Chen, Cheng
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16